| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 10/26/2004 | US6809090 Nitrogen monoxide synthase and/or lipidic peroxidation inhibitors |
| 10/26/2004 | US6809077 A cyclic polypeptides; immunosuppressive anti-inflammatory activity, inhibiting antigen-induced inflammatory cell infiltration |
| 10/26/2004 | US6808716 N-acetylamino acids, related N-acetyl compounds and their topical use |
| 10/26/2004 | US6808705 For suppressing the proliferation of cancer cells |
| 10/26/2004 | CA2294247C Antioxidant enhancement of therapy for hyperproliferative conditions |
| 10/26/2004 | CA2023811C Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
| 10/21/2004 | WO2004089913A1 Aminopyrimidine derivatives and their medical use |
| 10/21/2004 | WO2004089876A1 Biphenylcarboxylic amide derivatives as p38 kinease inhibitors |
| 10/21/2004 | WO2004089406A1 Topical composition in the form of a gel for treating skin burns |
| 10/21/2004 | WO2004089399A1 Novel uses of rfrp and ot7t022 |
| 10/21/2004 | WO2004089393A1 Photoaging inhibitor, photoaging-improving agent, collagenase inhibitor and tyrosinase inhibitor |
| 10/21/2004 | WO2004089391A1 Cosmetic powder for treatment of acne and method of making the same |
| 10/21/2004 | WO2004089390A2 Use of quinquina for the preparation of a medicament stimulating angiogenesis |
| 10/21/2004 | WO2004089388A1 The ready-prepared chinese medicine for treatment of hair loss and process of manufacturing thereof |
| 10/21/2004 | WO2004089368A1 Therapeutic or preventive agent for dermatitis |
| 10/21/2004 | WO2004089329A2 Topical compositions comprising n-acetylamino acids or related n-acetyl compounds |
| 10/21/2004 | WO2004089326A1 Cosmetic or dermatological preparations containing a combination of creatinine, creatine and bioquinones |
| 10/21/2004 | WO2004089282A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/21/2004 | WO2004076620A9 Human antibodies specific for interleukin 15 (il-15) |
| 10/21/2004 | WO2004075821A3 Cosmetic use of inositol |
| 10/21/2004 | WO2004071481B1 Melanogenesis inhibitor and skin preparation containing the same |
| 10/21/2004 | WO2004009556A9 4-(substituted aryl)-5-hydroxyisoquinolinone derivative |
| 10/21/2004 | WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/21/2004 | WO2003045228A3 Methods for treating autoimmune disorders, and reagents related thereto |
| 10/21/2004 | US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 10/21/2004 | US20040210040 Monoclonal antibodies for use in the prevention and treatment of cell proliferative and skin disorders; immunotherapy; antitumor agents |
| 10/21/2004 | US20040209959 X-Y, in which X is a benzyl group, a saturated or unsaturated cycloalkyl group or a non-cyclic, straight or branched alkyl group, optionally in combination with another analgesic, such as an NSAID or an opioid. |
| 10/21/2004 | US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 10/21/2004 | US20040209935 Pyrazole-derived kinase inhibitors and uses thereof |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 10/21/2004 | US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 10/21/2004 | US20040209901 substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors. |
| 10/21/2004 | US20040209894 e.g., 1-(4-chloroanilino)-4-[2-(pyridin-3-yl)-ethyl]-isoquinoline and 5-[4-(tert-butyl)-anilino]-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine |
| 10/21/2004 | US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 10/21/2004 | US20040209868 Substituted indoles |
| 10/21/2004 | US20040209856 Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 10/21/2004 | US20040209832 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| 10/21/2004 | US20040209819 Administering to the chronic skin ulcer an effective amount of a polypeptide of between 14 to 23 amino acids in length, cotnains a thrombin receptor binding domain of the sequence Arg-Gly-Asp-Ala (SEQ ID NO.: 7) and a serine esterase conserved sequence |
| 10/21/2004 | US20040209799 comprises inhibitors (cytokines) of janus kinases (JAK)/signal transducers and activators of transcription (STAT) other than debromohymenialdisine and hymensialdisine; gene expression inhibition; bioassay, immunoassay, drug screening; for treatment of degenerative joint diseases such as osteoarthritis |
| 10/21/2004 | US20040209359 Freeze-dried biocompatible matrix/biological scaffold comprising plasma proteins for use as implants in tissue engineering and biotechnology; wound healing agents |
| 10/21/2004 | US20040208941 Compositions for removal of toxins |
| 10/21/2004 | US20040208940 Wound and ulcer treatment with super-oxidized water |
| 10/21/2004 | US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability |
| 10/21/2004 | CA2521340A1 Aminopyrimidine derivatives and their medical use |
| 10/20/2004 | EP1469310A1 Diagnostic for scleroderma |
| 10/20/2004 | EP1468991A1 Imides as PDE III, PDE IV and TNF inhibitors |
| 10/20/2004 | EP1468696A1 Combinations of epinastine and antiphlogisitcs as new pharmaceutical compositions for the treatment of skin diseases |
| 10/20/2004 | EP1468693A2 Use of 2,6-di -alkyl-4-silyl-phenols for treating diabetes mellitus |
| 10/20/2004 | EP1468692A2 Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1467997A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 10/20/2004 | EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/20/2004 | EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof |
| 10/20/2004 | EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 10/20/2004 | EP1467965A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467745A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 10/20/2004 | EP1467744A2 Aqueous compositions containing metronidazole |
| 10/20/2004 | EP1467743A1 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application |
| 10/20/2004 | EP1467741A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 10/20/2004 | EP1467740A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 10/20/2004 | EP1467739A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 10/20/2004 | EP1467734A1 Cotherapy with an oxazolidinone and a vitamin b |
| 10/20/2004 | EP1467732A1 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| 10/20/2004 | EP1467731A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1467702A1 Cosmetic scar management composition |
| 10/20/2004 | EP1467701A2 Compositions and methods for high sorption of skin materials and delivery of sulfur |
| 10/20/2004 | EP1467622A2 Mitocidal compositions and methods |
| 10/20/2004 | EP1404180A4 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
| 10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 10/20/2004 | EP1194115B1 Topically applied idebenone-containing agent with protective and regenerative effect |
| 10/20/2004 | EP1171143B1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 10/20/2004 | EP1131291B1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 10/20/2004 | EP0862554B1 Aromatic carboxylic acid esters, the production of same and use of same as medicaments |
| 10/20/2004 | CN1539010A Fermentation product of cryptoporus volvatus and its preparation method and application |
| 10/20/2004 | CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease |
| 10/20/2004 | CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 10/20/2004 | CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them |
| 10/20/2004 | CN1538959A Fused-polycyclic compounds |
| 10/20/2004 | CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 10/20/2004 | CN1538855A Therapeutical solution for nuring wound and dressing material used with the theraputical solution |
| 10/20/2004 | CN1538853A T cell regulatory genes and methods of use thereof |
| 10/20/2004 | CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1537630A Medicine contg. bamboo viegar, chitosan and silver ion, and prepn. method and application thereof |
| 10/20/2004 | CN1537623A External-applied traditional Chinese medicine for dispelling toxicity with myogenic function |
| 10/20/2004 | CN1537622A Health-care food used for relaxing bowel, anti-senility and beautifying face |
| 10/20/2004 | CN1537561A Application of 'Ruzengning' and traditional Chinese medicine composition for preparing drug to treat chlosma disease |
| 10/20/2004 | CN1537557A Drug for external use with functions of sterilizing and relieving itching, and its prepn. method |
| 10/20/2004 | CN1537552A Spray for treating burn |
| 10/20/2004 | CN1537551A Traditional chinese medicine compositon for treating lipsotrichia and white hair, and nourishing hari, and its prepn. method |
| 10/20/2004 | CN1537548A Method for preparing traditional Chinese compound ointment |
| 10/20/2004 | CN1537538A Method for preparing compound flavone spray |